INI-822

N/A

Report date: 2023/07/18 20:00:33
NME

Base Information

Drug NameINI-822
Drug Alias NameINI-822
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of Action17-beta-hydroxysteroid dehydrogenase 13 inhibitors
Targets17-beta-hydroxysteroid dehydrogenase 13
Therapy Area/IndicationsFibrosisMetabolic Dysfunction-Associated Steatotic Liver Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesAustralia
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesInipharm Inc
China Registration ClassN/A

Develop Information

Active CompaniesInipharm Australia Pty LtdInipharm Inc
Inactive CompaniesN/A
Active IndicationsFibrosisMetabolic Dysfunction-Associated Steatotic Liver Disease
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A